Upgrade to SI Premium - Free Trial

Rothschild Redburn Starts MiniMed Group (MMED) at Buy

October 13, 2026 3:45 AM
Rothschild Redburn analyst Issie Kirby initiates coverage on MiniMed Group (NASDAQ: MMED) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments New Coverage